<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_ATOMS-Turkiye_Project_Module2_Data"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:ATOMS-Turkiye/Project/Module2:Data">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:ATOMS-Turkiye/Project/Module2:Data&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:ATOMS-Turkiye/Project/Module2:Data&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:ATOMS-Turkiye/Project/Module2:Data&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:ATOMS-Turkiye/Project/Module2:Data" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:ATOMS-Turkiye/Project/Module2:Data</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Data_Page:_Module_2"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Data Page: Module 2</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#BBa_K1202103_.E2.80.93_TAT-Apoptin_with_HlyA_Signal_Peptide"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">BBa_K1202103 – TAT-Apoptin with HlyA Signal Peptide</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#BBa_K1202104_.E2.80.93_TorA-GFP"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">BBa_K1202104 – TorA-GFP</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#BBa_K1202105_.E2.80.93_TAT-Apoptin:_Cancer_killing_peptide"><SPAN class="tocnumber">1.3</SPAN><SPAN class="toctext">BBa_K1202105 – TAT-Apoptin: Cancer killing peptide</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#BBa_K1202106_.E2.80.93_TAT-HA2-Apoptin:_Cancer_killing_peptide"><SPAN class="tocnumber">1.4</SPAN><SPAN class="toctext">BBa_K1202106 – TAT-HA2-Apoptin: Cancer killing peptide</SPAN></A></LI><LI class="toclevel-2 tocsection-6"><A href="#BBa_K1202107_.E2.80.93_TAT-E4-orf4:_Cancer_killing_peptide"><SPAN class="tocnumber">1.5</SPAN><SPAN class="toctext">BBa_K1202107 – TAT-E4-orf4: Cancer killing peptide</SPAN></A></LI><LI class="toclevel-2 tocsection-7"><A href="#BBa_K1202111_.E2.80.93_MPG-Apoptin:_Cancer_killing_peptide"><SPAN class="tocnumber">1.6</SPAN><SPAN class="toctext">BBa_K1202111 – MPG-Apoptin: Cancer killing peptide</SPAN></A></LI><LI class="toclevel-2 tocsection-8"><A href="#BBa_K1202112_.E2.80.93_GFP-HlyA"><SPAN class="tocnumber">1.7</SPAN><SPAN class="toctext">BBa_K1202112 – GFP-HlyA</SPAN></A></LI><LI class="toclevel-2 tocsection-9"><A href="#BBa_K1202113_.E2.80.93_TAT-RFP"><SPAN class="tocnumber">1.8</SPAN><SPAN class="toctext">BBa_K1202113 – TAT-RFP</SPAN></A></LI><LI class="toclevel-2 tocsection-10"><A href="#BBa_K1202115_.E2.80.93_TorA-TAT-Apoptin"><SPAN class="tocnumber">1.9</SPAN><SPAN class="toctext">BBa_K1202115 – TorA-TAT-Apoptin</SPAN></A></LI></UL></TD></TR></TBODY></TABLE><H2><SPAN class="mw-headline" id="Data_Page:_Module_2">Data Page: Module 2</SPAN></H2><H3><SPAN class="mw-headline" id="BBa_K1202103_.E2.80.93_TAT-Apoptin_with_HlyA_Signal_Peptide">BBa_K1202103 – TAT-Apoptin with HlyA Signal Peptide</SPAN></H3><P>Our cancer killing system, TAT-Apoptin, must be secreted from our bacteria. For this purpose, we decided to add HlyA signal peptide in the downstream region of our part. HlyA works only if it is placed in the N-terminus of protein. With this design, our TAT-Apoptin system can go out from bacteria.
</P><H3><SPAN class="mw-headline" id="BBa_K1202104_.E2.80.93_TorA-GFP">BBa_K1202104 – TorA-GFP</SPAN></H3><P>This construct is designed to test our TorA signal peptide function. In our plan, produced green fluorescent protein (GFP) must diffuse into the media via this signal peptide. Thus, this should allow us to measure it with excitation and emission assay. 
</P><H3><SPAN class="mw-headline" id="BBa_K1202105_.E2.80.93_TAT-Apoptin:_Cancer_killing_peptide">BBa_K1202105 – TAT-Apoptin: Cancer killing peptide</SPAN></H3><P>TAT-Apoptin was designed to induce programmed cell death (apoptosis) in cancer cells, selectively.  TAT signal peptide added to direct apoptin into cancer cells. 
</P><H3><SPAN class="mw-headline" id="BBa_K1202106_.E2.80.93_TAT-HA2-Apoptin:_Cancer_killing_peptide">BBa_K1202106 – TAT-HA2-Apoptin: Cancer killing peptide</SPAN></H3><P>HA2 peptide sequence is demonstrated that, with the combination of TAT, the cell penetrating activity increases considerably. We added HA2 in our TAT-Apoptin system to empower the yield of cancer killing mechanism. 
</P><H3><SPAN class="mw-headline" id="BBa_K1202107_.E2.80.93_TAT-E4-orf4:_Cancer_killing_peptide">BBa_K1202107 – TAT-E4-orf4: Cancer killing peptide</SPAN></H3><P>The general attitude to our parts is to designate alternative parts. For cancer killing mechanism, we searched through literature and found E4orf4 peptide. This derivative prospective cancer drug, like apoptin, induces apoptosis in cancer cells, selectively. Moreover, in literature and, of course iGEM, TAT-E4orf4 combination is completely novel.
</P><H3><SPAN class="mw-headline" id="BBa_K1202111_.E2.80.93_MPG-Apoptin:_Cancer_killing_peptide">BBa_K1202111 – MPG-Apoptin: Cancer killing peptide</SPAN></H3><P>We decided to use an alternative cell penetrating peptide instead of TAT. Likewise, MPG directs the attached protein into the eukaryotic cell cytoplasm. We want to use this activity to conduct our apoptosis inducing effect of our cancer killing proteins.
</P><H3><SPAN class="mw-headline" id="BBa_K1202112_.E2.80.93_GFP-HlyA">BBa_K1202112 – GFP-HlyA</SPAN></H3><P>This construct is designed to test our HlyA signal peptide function. In our plan, produced green fluorescent protein (GFP) must diffuse into the media via this signal peptide. Thus, this should allow us to measure it with excitation and emission assay. 
</P><H3><SPAN class="mw-headline" id="BBa_K1202113_.E2.80.93_TAT-RFP">BBa_K1202113 – TAT-RFP</SPAN></H3><P>This part is designed to measure the cell penetrating effect of TAT peptide. In our plan, in the case of good penetration, we could emit red fluorescent in cancer cell cytoplasm. This would allow us to say that our TAT directs the desired proteins into the cells efficiently.
</P><H3><SPAN class="mw-headline" id="BBa_K1202115_.E2.80.93_TorA-TAT-Apoptin">BBa_K1202115 – TorA-TAT-Apoptin</SPAN></H3><P>This part is designed to measure the secretion potency of our signal peptide, TorA, for our cancer killing peptides. To provide this, we plan to perform SDS-PAGE and Western blotting assays in supernatant samples by adding histidine tags to our peptides.
</P><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:ATOMS-Turkiye/Project/Module2:Data">http://2013.igem.org/Team:ATOMS-Turkiye/Project/Module2:Data</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:ATOMS-Turkiye/Project/Module2:Data" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:ATOMS-Turkiye/Project/Module2:Data" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:ATOMS-Turkiye/Project/Module2:Data&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:ATOMS-Turkiye/Project/Module2:Data&amp;oldid=315677" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>